Idexx Laboratories (IDXX) Current Deferred Revenue (2009 - 2026)
Idexx Laboratories (IDXX) posted Current Deferred Revenue of $36.4 million for Q2 2026, up 0.2% from $36.32 million a year earlier and up 0.2% from the prior quarter.
Idexx Laboratories (IDXX) Current Deferred Revenue (2009 - 2026) Analysis & Trends
At the end of FY2025, Idexx Laboratories' Current Deferred Revenue came in at $35.26 million, up 4.3% from FY2024.
- Annual Current Deferred Revenue shows a five-year compound annual growth rate of -3.7% (FY2020 to FY2025).
- In prior years, Idexx Laboratories' Current Deferred Revenue was $33.8 million in FY2024 (-9.1%), $37.2 million in FY2023 (-2.0%), $37.94 million in FY2022 (-5.2%) and $40.03 million in FY2021 (-6.0%).
- The Q2 2026 figure stands as the highest quarterly Current Deferred Revenue since Q3 2024.
- On a year-over-year basis, Current Deferred Revenue has increased in each of the last three quarters, with an average decline of 2.2% over the last eight quarters.
- The strongest year-over-year quarter for Current Deferred Revenue in the past five years was Q4 2025, with growth of 4.3%; the weakest was Q4 2024, with a decline of 9.1%.
- According to Business Quant data, Current Deferred Revenue for the three prior quarters was $36.33 million (Q1 2026), $35.26 million (Q4 2025) and $35.69 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn |
| 10 | Idexx Laboratories | 40.86 Bn | 40.07 Bn | 779.09 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.40 Mn |
| Mar 31, 2026 | 36.33 Mn |
| Dec 31, 2025 | 35.26 Mn |
| Sep 30, 2025 | 35.69 Mn |
| Jun 30, 2025 | 36.32 Mn |
| Mar 31, 2025 | 35.00 Mn |
| Dec 31, 2024 | 33.80 Mn |
| Sep 30, 2024 | 38.43 Mn |
| Jun 30, 2024 | 38.00 Mn |
| Mar 31, 2024 | 38.19 Mn |
| Dec 31, 2023 | 37.20 Mn |
| Sep 30, 2023 | 37.28 Mn |
| Jun 30, 2023 | 37.78 Mn |
| Mar 31, 2023 | 37.84 Mn |
| Dec 31, 2022 | 37.94 Mn |
| Sep 30, 2022 | 40.81 Mn |
| Jun 30, 2022 | 40.78 Mn |
| Mar 31, 2022 | 40.91 Mn |
| Dec 31, 2021 | 40.03 Mn |
| Sep 30, 2021 | 41.13 Mn |
Idexx Laboratories Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=IDXX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "IDXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=IDXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();